Deferasirox Reduces Oxidative Stress in Patients With Transfusion Dependency

Journal of Clinical Medicine Research
doi 10.4021/jocmr1180w
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elmer Press, Inc.

Related search

Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes

Haematologica
Hematology
2012English

Candesartan Reduces Oxidative Stress and Inflammation in Patients With Essential Hypertension

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2003English

N-Acetylcysteine Reduces Oxidative Stress in Sickle Cell Patients

Annals of Hematology
MedicineHematology
2012English

Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study

Annals of Hematology
MedicineHematology
2008English

Oxidative Stress in Patients With Endodontic Pathologies

Journal of Pain Research
AnesthesiologyPain Medicine
2017English

Oxidative Stress in Diabetic Patients With Retinopathy

Annals of African Medicine
Medicine
2014English

Oxidative Stress in Patients With Rheumatoid Arthritis

Mosul Journal of Nursing
2018English

Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients

American Journal of Hematology
Hematology
2018English

Oxidative Stress and DNA Damage in Patients With Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy